High dose IVIG (+/- Rituximab) desensitization alters sCD30 and BAFF levels in highly HLA sensitized patients

被引:0
|
作者
Lai, Chih-Hung [1 ]
Vo, Ashley [1 ]
Toyoda, Mieko [1 ]
Jordan, Stanley [1 ]
Reinsmoen, Nancy L. [1 ]
机构
[1] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:473 / 473
页数:1
相关论文
共 50 条
  • [1] IVIG plus single-dose rituximab is an effective desensitization strategy for highly-HLA sensitized patients
    Vo, Ashley A.
    Cao, Kai
    Lai, Chih-Hung
    Reinsmoen, Nancy
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Villicana, Rafael
    Kahwaji, Joseph
    Jordan, Stanley C.
    [J]. XENOTRANSPLANTATION, 2009, 16 (05) : 333 - 333
  • [2] Use of IVIG plus single dose rituximab for desensitization of highly-HLA sensitized patients awaiting kidney transplantation
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 181 - 181
  • [3] Long Term Outcomes in Highly-HLA Sensitized (HS) Patients Receiving Desensitization with IVIG and Single-Dose (SD) Rituximab.
    Vo, Ashley A.
    Cao, Kai
    Lai, Chih-Hung
    Reinsmoen, Nancy
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 557 - 557
  • [4] Analysis of Factors Associated with Unresponsiveness to Desensitization Using IVIG and Rituximab in Broadly HLA Sensitized Patients
    Vo, A. A.
    Choi, J.
    Kahwaji, J.
    Cisneros, K.
    Peng, A.
    Villicana, R.
    Reinsmoen, N.
    Lai, C. H.
    Cao, K.
    Jordan, S. C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 233 - 234
  • [5] Desensitization of highly HLA sensitized crossmatch (+) patients awaiting living donor (LD) kidney transplantation using IVIG plus Rituximab
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Lukovsky, Marina
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 353 - 353
  • [6] Sequential Dosing of Rituximab and IVIg for Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting HLAi Kidney Transplantation.
    Vo, A. A.
    Huang, E.
    Williamsons, S.
    Myers, C.
    Peng, A.
    Najjar, R.
    Sethi, S.
    Lim, K.
    Ammerman, N.
    Gordan, S. C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 812 - 813
  • [7] Donor HLA specific antibody and soluble CD30 levels as acute rejection risk factors for patients in high dose IVIG/rituximab desensitization protocols.
    Nancy, Reinsmoen L.
    Lai, Chih-Hung
    Ong, Geraldine
    Naim, Mehmoush
    Vo, Ashley
    Jordan, Stanley
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 410 - 410
  • [8] Lack of Effect in Desensitization with IVIG and Rituximab in Highly-Sensitized Patients on Top of the Waiting List
    Marfo, K.
    Ling, M.
    Bao, Y.
    Lu, A.
    Greenstein, S.
    Chapochnick, J.
    Lindower, J.
    Glicklich, D.
    de Boccardo, G.
    Kinkhabwala, M.
    Akalin, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 90 - 90
  • [9] Preliminary Outcome of Desensitization With Super High Dose IVIG, Plasmapheresis, and Rituximab for Crossmatch-Positive (Highly Sensitized) Kidney Transplant Recipients
    Omoto, K.
    Furusawa, M.
    Shimizu, T.
    Inui, M.
    Nozaki, T.
    Toki, D.
    Shirakawa, H.
    Ishida, H.
    Tanabe, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 451 - 451
  • [10] Preliminary Outcome of Desensitization With Super High Dose IVIG, Plasmapheresis, and Rituximab for Crossmatch-Positive (Highly Sensitized) Kidney Transplant Recipients
    Omoto, K.
    Furusawa, M.
    Shimizu, T.
    Inui, M.
    Nozaki, T.
    Toki, D.
    Shirakawa, H.
    Ishida, H.
    Tanabe, K.
    [J]. TRANSPLANTATION, 2014, 98 : 451 - 451